{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:41:12Z","timestamp":1790804472026,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T00:00:00Z","timestamp":1624924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s00296-021-04937-w","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T17:02:52Z","timestamp":1624986172000},"page":"303-309","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study"],"prefix":"10.1007","volume":"42","author":[{"given":"Vasiliki-Kalliopi","family":"Bournia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Kallianos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos","family":"Panopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Gialafos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lemonia","family":"Velentza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis G.","family":"Vlachoyiannopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros P.","family":"Sfikakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0037-1269","authenticated-orcid":false,"given":"Georgia","family":"Trakada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,29]]},"reference":[{"key":"4937_CR1","first-page":"103","volume":"32","author":"E Rosato","year":"2014","unstructured":"Rosato E, Romaniello A, Magr\u00ec D et al (2014) Exercise tolerance in systemic sclerosis patients without pulmonary impairment: correlation with clinical variables. Clin Exp Rheumatol 32:103\u20138","journal-title":"Clin Exp Rheumatol"},{"key":"4937_CR2","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3109\/03009740903555358","volume":"39","author":"G Cuomo","year":"2010","unstructured":"Cuomo G, Santoriello C, Polverino F et al (2010) Impaired exercise performance in systemic sclerosis and its clinical correlations. Scand J Rheumatol 39:330\u2013335. https:\/\/doi.org\/10.3109\/03009740903555358","journal-title":"Scand J Rheumatol"},{"key":"4937_CR3","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.3899\/jrheum.091424","volume":"37","author":"AJ Walkey","year":"2010","unstructured":"Walkey AJ, Ieong M, Alikhan M, Farber HW (2010) Cardiopulmonary exercise testing with right-heart catheterization in patients with systemic sclerosis. J Rheumatol 37:1871\u20131877. https:\/\/doi.org\/10.3899\/jrheum.091424","journal-title":"J Rheumatol"},{"key":"4937_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/2397198317747441","volume":"3","author":"V-K Bournia","year":"2018","unstructured":"Bournia V-K, Tountas C, Protogerou AD et al (2018) Update on assessment and management of primary cardiac involvement in systemic sclerosis. J Scleroderma Relat Disord 3:53\u201365. https:\/\/doi.org\/10.1177\/2397198317747441","journal-title":"J Scleroderma Relat Disord"},{"key":"4937_CR5","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/J.RDC.2015.04.011","volume":"41","author":"K Morrisroe","year":"2015","unstructured":"Morrisroe K, Nikpour M, Proudman S (2015) Musculoskeletal manifestations of systemic sclerosis. Rheum Dis Clin North Am 41:507\u2013518. https:\/\/doi.org\/10.1016\/J.RDC.2015.04.011","journal-title":"Rheum Dis Clin North Am"},{"key":"4937_CR6","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0101-2018","volume":"28","author":"T Radtke","year":"2019","unstructured":"Radtke T, Crook S, Kaltsakas G et al (2019) ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases. Eur Respir Rev 28:180101. https:\/\/doi.org\/10.1183\/16000617.0101-2018","journal-title":"Eur Respir Rev"},{"key":"4937_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1183\/13993003.00745-2015","volume":"47","author":"L Puente-Maestu","year":"2016","unstructured":"Puente-Maestu L, Palange P, Casaburi R et al (2016) Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J 47:429\u2013460. https:\/\/doi.org\/10.1183\/13993003.00745-2015","journal-title":"Eur Respir J"},{"key":"4937_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1164\/rccm.167.2.211","volume":"167","author":"American Thoracic Society","year":"2003","unstructured":"American Thoracic Society (2003) Board of Directors, and American College of Chest Physicians (ACCP) Health Science Policy Committee. ATS\/ACCP Statement on Cardiopulmonary Exercise Testing. Am J Respir Crit Care Med 167:211\u2013277. https:\/\/doi.org\/10.1164\/rccm.167.2.211","journal-title":"Am J Respir Crit Care Med"},{"key":"4937_CR9","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1249\/MSS.0b013e31817c92c0","volume":"40","author":"H Groepenhoff","year":"2008","unstructured":"Groepenhoff H, Vonk-Noordegraaf A, Boonstra A et al (2008) Exercise testing to estimate survival in pulmonary hypertension. Med Sci Sports Exerc 40:1725\u20131732. https:\/\/doi.org\/10.1249\/MSS.0b013e31817c92c0","journal-title":"Med Sci Sports Exerc"},{"key":"4937_CR10","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1183\/09031936.00217911","volume":"40","author":"G Deboeck","year":"2012","unstructured":"Deboeck G, Scoditti C, Huez S et al (2012) Exercise testing to predict outcome in idiopathic versus associated pulmonary arterial hypertension. Eur Respir J 40:1410\u20131419. https:\/\/doi.org\/10.1183\/09031936.00217911","journal-title":"Eur Respir J"},{"key":"4937_CR11","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12890-019-1003-7","volume":"19","author":"R Ewert","year":"2019","unstructured":"Ewert R, Ittermann T, Habedank D et al (2019) Prognostic value of cardiopulmonary exercise testing in patients with systemic sclerosis. BMC Pulm Med 19:230. https:\/\/doi.org\/10.1186\/s12890-019-1003-7","journal-title":"BMC Pulm Med"},{"key":"4937_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1183\/09031936.05.00034505","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Crapo R, Hankinson J et al (2005) General considerations for lung function testing. Eur Respir J 26:153\u2013161. https:\/\/doi.org\/10.1183\/09031936.05.00034505","journal-title":"Eur Respir J"},{"key":"4937_CR13","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.autrev.2018.02.008","volume":"17","author":"S Panopoulos","year":"2018","unstructured":"Panopoulos S, Bournia V-K, Konstantonis G et al (2018) Predictors of morbidity and mortality in early systemic sclerosis: Long-term follow-up data from a single-centre inception cohort. Autoimmun Rev 17:816\u2013820. https:\/\/doi.org\/10.1016\/j.autrev.2018.02.008","journal-title":"Autoimmun Rev"},{"key":"4937_CR14","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3899\/jrheum.120667","volume":"40","author":"ST Panopoulos","year":"2013","unstructured":"Panopoulos ST, Bournia VK, Sfikakis PP (2013) Is vasculopathy associated with systemic sclerosis more severe in men? J Rheumatol 40:46\u201351. https:\/\/doi.org\/10.3899\/jrheum.120667","journal-title":"J Rheumatol"},{"key":"4937_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001728","volume":"94","author":"CP Sime\u00f3n-Aznar","year":"2015","unstructured":"Sime\u00f3n-Aznar CP, Fonollosa-Pl\u00e1 V, Tolosa-Vilella C et al (2015) Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of Death. Medicine (Baltimore) 94:e1728. https:\/\/doi.org\/10.1097\/MD.0000000000001728","journal-title":"Medicine (Baltimore)"},{"key":"4937_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/J.SEMARTHRIT.2008.06.002","volume":"39","author":"FF Al-Dhaher","year":"2010","unstructured":"Al-Dhaher FF, Pope JE, Ouimet JM (2010) Determinants of Morbidity and Mortality of Systemic Sclerosis in Canada. Semin Arthritis Rheum 39:269\u2013277. https:\/\/doi.org\/10.1016\/J.SEMARTHRIT.2008.06.002","journal-title":"Semin Arthritis Rheum"},{"key":"4937_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00005792-200203000-00004","volume":"81","author":"C Ferri","year":"2002","unstructured":"Ferri C, Valentini G, Cozzi F et al (2002) Demographic, clinical and serologic features and survival in 1,012 Italian Patients. Medicine (Baltimore) 81:139\u2013153","journal-title":"Medicine (Baltimore)"},{"key":"4937_CR18","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/art.23718","volume":"59","author":"O Distler","year":"2008","unstructured":"Distler O, Behrens F, Pittrow D et al (2008) Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis. Arthritis Rheum 59:867\u2013875. https:\/\/doi.org\/10.1002\/art.23718","journal-title":"Arthritis Rheum"},{"key":"4937_CR19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.3390\/ph14040342","volume":"14","author":"M Bellan","year":"2021","unstructured":"Bellan M, Giubertoni A, Piccinino C et al (2021) Cardiopulmonary exercise testing is an accurate tool for the diagnosis of pulmonary arterial hypertension in scleroderma related diseases. Pharmaceuticals (Basel) 14:342. https:\/\/doi.org\/10.3390\/ph14040342","journal-title":"Pharmaceuticals (Basel)"},{"key":"4937_CR20","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1136\/heartjnl-2016-309981","volume":"103","author":"D Dumitrescu","year":"2017","unstructured":"Dumitrescu D, Nagel C, Kovacs G et al (2017) Cardiopulmonary exercise testing for detecting pulmonary arterial hypertension in systemic sclerosis. Heart 103:774\u2013782. https:\/\/doi.org\/10.1136\/heartjnl-2016-309981","journal-title":"Heart"},{"key":"4937_CR21","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1093\/rheumatology\/kez473","volume":"59","author":"A Santaniello","year":"2020","unstructured":"Santaniello A, Casella R, Vicenzi M et al (2020) Cardiopulmonary exercise testing in a combined screening approach to individuate pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 59:1581\u20131586. https:\/\/doi.org\/10.1093\/rheumatology\/kez473","journal-title":"Rheumatology (Oxford)"},{"key":"4937_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1378\/chest.09-2099","volume":"138","author":"G Kovacs","year":"2010","unstructured":"Kovacs G, Maier R, Aberer E et al (2010) Assessment of pulmonary arterial pressure during exercise in collagen vascular disease: echocardiography vs right-sided heart catheterization. Chest 138:270\u2013278. https:\/\/doi.org\/10.1378\/chest.09-2099","journal-title":"Chest"},{"key":"4937_CR23","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1159\/000442888","volume":"91","author":"AK Boutou","year":"2016","unstructured":"Boutou AK, Pitsiou GG, Siakka P et al (2016) Phenotyping exercise limitation in systemic sclerosis: the use of cardiopulmonary exercise testing. Respiration 91:115\u2013123. https:\/\/doi.org\/10.1159\/000442888","journal-title":"Respiration"},{"key":"4937_CR24","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000444091","volume":"91","author":"V Tzilas","year":"2016","unstructured":"Tzilas V, Bouros D (2016) Cardiopulmonary exercise testing in systemic sclerosis: \u2018Ars longa, vita brevis\u2019\u2019\u2019. Respiration 91:202\u2013203. https:\/\/doi.org\/10.1159\/000444091","journal-title":"Respiration"},{"key":"4937_CR25","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3899\/jrheum.161349","volume":"45","author":"N Martis","year":"2018","unstructured":"Martis N, Queyrel-Moranne V, Launay D et al (2018) Limited exercise capacity in patients with systemic sclerosis: identifying contributing factors with cardiopulmonary exercise testing. J Rheumatol 45:95\u2013102. https:\/\/doi.org\/10.3899\/jrheum.161349","journal-title":"J Rheumatol"},{"key":"4937_CR26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014293","volume":"5","author":"D Dumitrescu","year":"2010","unstructured":"Dumitrescu D, Oudiz RJ, Karpouzas G et al (2010) Developing pulmonary vasculopathy in systemic sclerosis, detected with non-invasive cardiopulmonary exercise testing. PLoS ONE 5:e14293. https:\/\/doi.org\/10.1371\/journal.pone.0014293","journal-title":"PLoS ONE"},{"key":"4937_CR27","doi-asserted-by":"crossref","unstructured":"Hemelein RA, Lajk\u00f3 I, Bar\u00e1th K et al (2021) Evaluation of cardiopulmonary exercise test in the prediction of disease progression in systemic sclerosis. Clin Exp Rheumatol, Epub ahead of print. PMID: 33769261","DOI":"10.55563\/clinexprheumatol\/tktu8v"},{"key":"4937_CR28","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.4187\/RESPCARE.04471","volume":"61","author":"B Vainshelboim","year":"2016","unstructured":"Vainshelboim B, Oliveira J, Fox BD, Kramer MR (2016) The prognostic role of ventilatory inefficiency and exercise capacity in idiopathic pulmonary fibrosis. Respir Care 61:1100\u20131109. https:\/\/doi.org\/10.4187\/RESPCARE.04471","journal-title":"Respir Care"},{"key":"4937_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/514817","author":"C Triantafillidou","year":"2013","unstructured":"Triantafillidou C, Manali E, Lyberopoulos P et al (2013) The role of cardiopulmonary exercise test in IPF prognosis. Pulm Med. https:\/\/doi.org\/10.1155\/2013\/514817","journal-title":"Pulm Med"},{"key":"4937_CR30","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1513\/AnnalsATS.201612-997FR","volume":"14","author":"A Mezzani","year":"2017","unstructured":"Mezzani A (2017) Cardiopulmonary exercise testing: basics of methodology and measurements. Ann Am Thorac Soc 14:S3\u2013S11. https:\/\/doi.org\/10.1513\/AnnalsATS.201612-997FR","journal-title":"Ann Am Thorac Soc"},{"key":"4937_CR31","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1378\/chest.13-2626","volume":"146","author":"TA Winstone","year":"2014","unstructured":"Winstone TA, Assayag D, Wilcox PG et al (2014) Predictors of mortality and progression in scleroderma-associated interstitial lung disease. Chest 146:422\u2013436. https:\/\/doi.org\/10.1378\/chest.13-2626","journal-title":"Chest"},{"key":"4937_CR32","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0889-857X(03)00025-5","volume":"29","author":"B White","year":"2003","unstructured":"White B (2003) Interstitial lung disease in scleroderma. Rheum Dis Clin North Am 29:371\u2013390. https:\/\/doi.org\/10.1016\/S0889-857X(03)00025-5","journal-title":"Rheum Dis Clin North Am"},{"key":"4937_CR33","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972\u20132002. Ann Rheum Dis 66:940\u2013944. https:\/\/doi.org\/10.1136\/ard.2006.066068","journal-title":"Ann Rheum Dis"},{"key":"4937_CR34","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0102-2017","volume":"27","author":"M Caron","year":"2018","unstructured":"Caron M, Hoa S, Hudson M et al (2018) Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease. Eur Respir Rev 27:170102. https:\/\/doi.org\/10.1183\/16000617.0102-2017","journal-title":"Eur Respir Rev"},{"key":"4937_CR35","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/art.40130","volume":"69","author":"NS Goh","year":"2017","unstructured":"Goh NS, Hoyles RK, Denton CP et al (2017) Short-term pulmonary function trends are predictive of mortality in interstitial lung disease associated with systemic sclerosis. Arthritis Rheumatol 69:1670\u20131678. https:\/\/doi.org\/10.1002\/art.40130","journal-title":"Arthritis Rheumatol"},{"key":"4937_CR36","doi-asserted-by":"publisher","first-page":"1902026","DOI":"10.1183\/13993003.02026-2019","volume":"55","author":"O Distler","year":"2020","unstructured":"Distler O, Assassi S, Cottin V et al (2020) Predictors of progression in systemic sclerosis patients with interstitial lung disease. Eur Respir J 55:1902026. https:\/\/doi.org\/10.1183\/13993003.02026-2019","journal-title":"Eur Respir J"},{"key":"4937_CR37","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1056\/NEJMoa1903076","volume":"380","author":"O Distler","year":"2019","unstructured":"Distler O, Highland KB, Gahlemann M et al (2019) Nintedanib for systemic sclerosis-associated interstitial lung disease. N Engl J Med 380:2518\u20132528. https:\/\/doi.org\/10.1056\/NEJMoa1903076","journal-title":"N Engl J Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04937-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04937-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04937-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:28:20Z","timestamp":1672619300000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04937-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,29]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["4937"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04937-w","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,29]]},"assertion":[{"value":"6 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"VKB has received a conference Grant from GSK and Lecture honoraria from Boehringer Ingelheim. PPS has received Consulting Fees from Actelion, Pfizer, Genesis, MSD, UCB, Boehringer Ingelheim, Enorasis, Farmaserv-Lilly, Gilead, Abbvie, Novartis and Research Grants from Abbvie, Roche, Pfizer, Faran, Amgen, Jannsen, Boehringer Ingelheim, Gilead.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/Competing interests"}},{"value":"Informed consent obtained from all study participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Approved from the Alexandra Hospital Ethics Committee\/Scientific Council.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}